Ironwood Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US46333X1081

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Bryan E Roberts. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Bryan E Roberts har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TXG / 10x Genomics, Inc. Director 88.503
US:CSLT / Castlight Health Inc - Class B Director, 10% Owner 0
US:AKAO / Achaogen, Inc. Director 15.000
US:VTAE / Vitae Pharmaceuticals, Inc. Director 10.000
US:ZLTQ / ZELTIQ Aesthetics, Inc. Director 7.418
US:IRWD / Ironwood Pharmaceuticals, Inc. Director 31.951
US:032420AC5 / Anacor Pharmaceuticals Inc. Bond 2.0% 15 OCT 2021 10% Owner 3.575.535
US:NBIX / Neurocrine Biosciences, Inc. 10% Owner 4.044.789
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Bryan E Roberts. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb IRWD / Ironwood Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i IRWD / Ironwood Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IRWD / Ironwood Pharmaceuticals, Inc. Insider Trades
Insidersalg IRWD / Ironwood Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i IRWD / Ironwood Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-03-10 IRWD ROBERTS BRYAN E 105 15,0700 105 15,0700 1.582 335 6.714 -877 -55,44
2015-03-10 IRWD ROBERTS BRYAN E 82.270 15,1700 82.270 15,1700 1.248.036
2015-03-10 IRWD ROBERTS BRYAN E 6.975 15,1700 6.975 15,1700 105.811
2015-03-09 IRWD ROBERTS BRYAN E 148 15,6200 148 15,6200 2.312
2015-03-09 IRWD ROBERTS BRYAN E 5.992 15,6300 5.992 15,6300 93.655
2015-03-09 IRWD ROBERTS BRYAN E 508 15,6300 508 15,6300 7.940
2014-12-15 IRWD ROBERTS BRYAN E 1.200 15,0600 1.200 15,0600 18.072
2014-12-12 IRWD ROBERTS BRYAN E 18.592 15,2100 18.592 15,2100 282.784
2014-06-12 IRWD ROBERTS BRYAN E 168.086 14,2400 168.086 14,2400 2.393.545
2014-06-12 IRWD ROBERTS BRYAN E 31.914 14,2400 31.914 14,2400 454.455
2014-06-09 IRWD ROBERTS BRYAN E 242.753 14,5200 242.753 14,5200 3.524.774
2014-06-09 IRWD ROBERTS BRYAN E 46.093 14,5200 46.093 14,5200 669.270
2014-05-30 IRWD ROBERTS BRYAN E 345.544 14,5200 345.544 14,5200 5.017.299
2014-05-30 IRWD ROBERTS BRYAN E 65.610 14,5200 65.610 14,5200 952.657

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IRWD / Ironwood Pharmaceuticals, Inc. Insider Trades
Insiderkøb TXG / 10x Genomics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i IRWD / Ironwood Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-09-16 TXG ROBERTS BRYAN E 300.000 39,0000 300.000 39,0000 11.700.000 361 125 25.800.000 220,51

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TXG / 10x Genomics, Inc. Insider Trades
Insidersalg TXG / 10x Genomics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i IRWD / Ironwood Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-05-20 TXG ROBERTS BRYAN E 3.100.000 78,0000 3.100.000 78,0000 241.800.000 2 74.85 -9.765.000 -4,04

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TXG / 10x Genomics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Bryan E Roberts som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-06-16 2023-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 1.865 88.503 2,15
2023-05-19 2023-05-17 4 TXG 10x Genomics, Inc.
Class A Common Stock
C - Conversion 3.790.422 3.790.422
2022-06-17 2022-06-15 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 2.120 2.745 339,20
2022-02-18 2022-02-17 4 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
D - Sale to Issuer -15.568.571 0 -100,00
2022-02-18 2022-02-17 4 CSLT CASTLIGHT HEALTH, INC.
Director Stock Option (right to buy)
D - Sale to Issuer -25.000 0 -100,00
2022-02-18 2022-02-17 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
D - Sale to Issuer -5.255.264 0 -100,00
2022-02-18 2022-02-17 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
D - Sale to Issuer -405.184 0 -100,00
2021-06-15 2021-06-11 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 1.563 1.563
2021-06-15 2021-06-11 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 625 625
2021-06-14 2021-06-10 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 70.707 405.184 21,14
2021-05-04 2021-04-30 4 TXG 10x Genomics, Inc.
Class B Common Stock
C - Conversion -2.000.000 3.790.422 -34,54
2021-05-04 2021-04-30 4 TXG 10x Genomics, Inc.
Class A Common Stock
C - Conversion 2.000.000 2.037.825 5.287,51
2021-02-12 2020-12-22 5 TXG 10x Genomics, Inc.
Class A Common Stock
G - Gift 46.500 46.500
2021-02-12 2020-12-22 5 TXG 10x Genomics, Inc.
Class A Common Stock
G - Gift -46.500 168.791 -21,60
2020-12-10 2020-12-10 4 TXG 10x Genomics, Inc.
Class A Common Stock
J - Other 93.487 215.291 76,75
2020-12-10 2020-12-10 4 TXG 10x Genomics, Inc.
Class A Common Stock
J - Other -268.692 2.037.825 -11,65
2020-12-10 2020-12-08 4 TXG 10x Genomics, Inc.
Class B Common Stock
C - Conversion -3.000.000 5.790.422 -34,13
2020-12-10 2020-12-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
J - Other -731.308 2.306.517 -24,07
2020-12-10 2020-12-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
C - Conversion 3.000.000 3.037.825 7.931,26
2020-09-18 2020-09-18 4 TXG 10x Genomics, Inc.
Class A Common Stock
J - Other 121.804 121.804
2020-09-18 2020-09-18 4 TXG 10x Genomics, Inc.
Class A Common Stock
J - Other -338.019 37.825 -89,94
2020-09-18 2020-09-16 4 TXG 10x Genomics, Inc.
Class A Common Stock
J - Other -911.981 375.844 -70,82
2020-06-17 2020-06-15 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 4.432 4.432
2020-06-05 2020-06-03 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 180.645 334.477 117,43
2020-05-22 2020-05-20 4 TXG 10x Genomics, Inc.
Class B Common Stock
C - Conversion -2.156.088 8.790.422 -19,70
2020-05-22 2020-05-20 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -3.100.000 1.287.825 -70,65 78,00 -241.800.000 100.450.350
2020-05-22 2020-05-20 4 TXG 10x Genomics, Inc.
Class A Common Stock
C - Conversion 2.156.088 4.387.825 96,61
2020-05-01 2020-05-01 4 TXG 10x Genomics, Inc.
Class B Common Stock
C - Conversion -1.931.737 10.946.510 -15,00
2020-05-01 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
C - Conversion 1.931.737 2.231.737 643,91
2019-09-17 2019-09-16 4/A TXG 10x Genomics, Inc.
Class A Common Stock
P - Purchase 300.000 300.000 39,00 11.700.000 11.700.000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Class B Common Stock
C - Conversion 12.878.247 12.878.247
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Series C Preferred Stock
C - Conversion -1.786.431 0 -100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Series B Preferred Stock
C - Conversion -3.272.171 0 -100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Series A-2 Preferred Stock
C - Conversion -7.819.645 0 -100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Class A Common Stock
P - Purchase 300.000 300.000 39,00 11.700.000 11.700.000
2019-09-12 2019-09-11 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 40.000 40.000
2019-06-07 2019-06-05 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 44.164 153.832 40,27
2019-06-07 2017-04-03 4/A CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 3.998.534 5.255.264 318,17
2018-06-22 2018-06-20 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 32.183 109.668 41,53
2018-06-07 2018-06-05 4 AKAO Achaogen Inc
Stock Option (Right to Buy)
A - Award 15.000 15.000
2017-06-26 2017-06-22 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 33.735 77.485 77,11
2017-06-16 2017-06-14 4 AKAO Achaogen Inc
Stock Option (Right to Buy)
A - Award 10.000 10.000
2017-04-05 2017-04-03 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 3.965.979 5.222.709 315,58
2016-06-23 2016-06-22 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 31.250 43.750 250,00
2016-06-17 2016-06-15 4 AKAO Achaogen Inc
Stock Option (Right to Buy)
A - Award 10.000 10.000
2016-05-27 2016-05-26 4 VTAE Vitae Pharmaceuticals, Inc
Stock Option (Right to Buy)
A - Award 10.000 10.000
2015-11-20 2015-11-18 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
P - Purchase 121.300 1.256.730 10,68 3,85 467.005 4.838.410
2015-11-16 2015-11-16 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
P - Purchase 51.127 1.135.430 4,72 3,84 196.328 4.360.051
2015-11-16 2015-11-13 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
P - Purchase 56.242 1.084.303 5,47 3,85 216.532 4.174.567
2015-11-16 2015-11-12 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
P - Purchase 22.061 1.028.061 2,19 3,85 84.935 3.958.035
2015-11-10 2015-11-10 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
P - Purchase 350.000 1.006.000 53,35 3,77 1.319.500 3.792.620
2015-11-10 2015-11-09 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
P - Purchase 125.000 656.000 23,54 3,84 480.000 2.519.040
2015-11-10 2015-11-06 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
P - Purchase 531.000 531.000 3,81 2.023.110 2.023.110
2015-11-04 2015-11-04 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 7.338 7.418 9.172,50
2015-11-04 2015-11-04 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -815 0 -100,00
2015-11-04 2015-11-04 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -3.280 0 -100,00
2015-11-04 2015-11-04 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -38.614 0 -100,00
2015-11-04 2015-11-02 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 815 815
2015-11-04 2015-11-02 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 3.280 3.280
2015-11-04 2015-11-02 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 38.614 38.614
2015-11-04 2015-11-02 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -1.729.117 1.729.116 -50,00
2015-07-23 2015-07-22 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
A - Award 790 5.786 15,81
2015-06-22 2015-06-17 4/A CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 12.500 12.500
2015-06-18 2015-06-17 4 CSLT CASTLIGHT HEALTH, INC.
Class B Common Stock
A - Award 12.500 12.500
2015-06-18 2015-06-17 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
A - Award 4.996 4.996
2015-06-16 2015-06-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 145 31.951 0,46 12,06 1.749 385.329
2015-06-11 2015-06-10 4 AKAO Achaogen Inc
Stock Option (Right to Buy)
A - Award 10.000 10.000
2015-06-05 2015-06-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 16.556 31.806 108,56
2015-06-01 2015-05-28 4 VTAE Vitae Pharmaceuticals, Inc
Stock Option (Right to Buy)
A - Award 10.000 10.000
2015-03-17 2015-03-13 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 165 15.250 1,09 15,07 2.487 229.818
2015-03-11 2015-03-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -6.975 0 -100,00 15,17 -105.811
2015-03-11 2015-03-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -82.270 0 -100,00 15,17 -1.248.036
2015-03-11 2015-03-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -105 0 -100,00 15,07 -1.582
2015-03-11 2015-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -508 6.975 -6,79 15,63 -7.940 109.019
2015-03-11 2015-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -5.992 82.270 -6,79 15,63 -93.655 1.285.880
2015-03-11 2015-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -148 105 -58,50 15,62 -2.312 1.640
2015-03-05 2015-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other 64 15.085 0,43
2015-03-05 2015-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other 148 253 140,95
2015-03-05 2015-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other -1.919.704 0 -100,00
2015-03-05 2015-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other -16.498 0 -100,00
2014-12-16 2014-12-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 182 15.401 1,20 13,70 2.493 210.994
2014-12-16 2014-12-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -1.200 16.498 -6,78 15,06 -18.072 248.460
2014-12-16 2014-12-12 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -18.592 17.698 -51,23 15,21 -282.784 269.187
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series C Preferred Stock
C - Conversion -1.031 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series C Preferred Stock
C - Conversion -41.270 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series C Preferred Stock
C - Conversion -9.285 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series B Preferred Stock
C - Conversion -25.233 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series B Preferred Stock
C - Conversion -1.009.414 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series B Preferred Stock
C - Conversion -227.117 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
C - Conversion -3.563 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
C - Conversion -142.607 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
C - Conversion -32.086 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
P - Purchase 15.446 47.077 48,83 8,00 123.568 376.616
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
P - Purchase 617.868 1.883.372 48,82 8,00 4.942.944 15.066.976
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
P - Purchase 139.019 423.754 48,82 8,00 1.112.152 3.390.032
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 1.031 31.631 3,37
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 41.270 1.265.504 3,37
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 9.285 284.735 3,37
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 25.233 30.600 470,15
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 1.009.414 1.224.234 469,89
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 227.117 275.450 469,90
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 5.367 5.367
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 214.820 214.820
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 48.333 48.333
2014-09-26 2014-09-24 4 VTAE Vitae Pharmaceuticals, Inc
Stock Option (Right to Buy)
A - Award 17.000 17.000
2014-09-17 2014-09-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 198 15.219 1,32 12,59 2.493 191.607
2014-08-26 2014-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
C - Conversion 36.290 36.290
2014-08-26 2014-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -36.290 0 -100,00
2014-08-26 2014-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
C - Conversion 1.919.704 1.919.704
2014-08-26 2014-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -1.919.704 0 -100,00
2014-06-16 2014-06-13 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 170 44.503 0,38 14,66 2.492 652.414
2014-06-16 2014-06-12 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -31.914 0 -100,00 14,24 -454.455
2014-06-16 2014-06-12 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -168.086 0 -100,00 14,24 -2.393.545
2014-06-11 2014-06-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -46.093 31.914 -59,09 14,52 -669.270 463.391
2014-06-11 2014-06-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -242.753 168.086 -59,09 14,52 -3.524.774 2.440.609
2014-06-05 2014-06-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 19.778 44.333 80,55
2014-06-03 2014-05-30 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -65.610 78.007 -45,68 14,52 -952.657 1.132.662
2014-06-03 2014-05-30 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -345.544 410.839 -45,68 14,52 -5.017.299 5.965.382
2014-06-03 2014-05-30 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (right to buy)
A - Award 30.000 30.000
2014-03-19 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Class A Common Stock
C - Conversion 15.382.556 15.568.571 8.269,52
2014-03-19 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series D Convertible Preferred Stock
C - Conversion -303.650 0 -100,00
2014-03-19 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series C Convertible Preferred Stock
C - Conversion -924.373 0 -100,00
2014-03-19 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series B Convertible Preferred Stock
C - Conversion -3.617.117 0 -100,00
2014-03-19 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series A-1 Convertible Preferred Stock
C - Conversion -6.630.686 0 -100,00
2014-03-19 2014-03-19 4 CSLT CASTLIGHT HEALTH, INC.
Series A Convertible Preferred Stock
C - Conversion -3.906.730 0 -100,00
2014-03-18 2014-03-14 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 195 24.555 0,80 12,76 2.488 313.322
2014-03-17 2014-03-13 4 CSLT CASTLIGHT HEALTH, INC.
Director Stock Option (right to buy)
A - Award 25.000 25.000
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series D Preferred Stock
C - Conversion -382.913 0 -100,00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series C Preferred Stock
C - Conversion -725.873 0 -100,00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series B Preferred Stock
C - Conversion -223.440 0 -100,00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series A Preferred Stock
C - Conversion -296.981 0 -100,00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Common Stock
C - Conversion 382.913 1.746.461 28,08
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Common Stock
C - Conversion 725.873 1.363.548 113,83
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Common Stock
C - Conversion 296.878 637.675 87,11
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Common Stock
C - Conversion 340.797 340.797
2014-03-13 2014-03-11 4 AKAO Achaogen Inc
Stock Option (right to buy)
A - Award 10.000 10.000
2014-03-06 2014-02-25 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
G - Gift -8.000 80 -99,01
2014-02-26 2014-02-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other -931.248 0 -100,00
2014-01-27 2014-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other -931.249 931.248 -50,00
2014-01-27 2014-01-27 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 8.080 8.080
2014-01-27 2014-01-27 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -934 0 -100,00
2014-01-27 2014-01-27 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -3.749 0 -100,00
2014-01-27 2014-01-27 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -44.265 0 -100,00
2014-01-27 2014-01-23 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 934 934
2014-01-27 2014-01-23 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 3.749 3.749
2014-01-27 2014-01-23 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other 44.265 44.265
2014-01-27 2014-01-23 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
J - Other -2.000.000 3.458.233 -36,64
2014-01-16 2014-01-14 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -3.383 143.617 -2,30 12,57 -42.524 1.805.266
2014-01-16 2014-01-14 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -17.817 756.383 -2,30 12,57 -223.960 9.507.734
2014-01-13 2014-01-13 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -40.603 147.000 -21,64 12,57 -510.380 1.847.790
2014-01-13 2014-01-13 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -213.840 774.200 -21,64 12,57 -2.687.969 9.731.694
2014-01-13 2014-01-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -47.873 187.603 -20,33 13,12 -628.094 2.461.351
2014-01-13 2014-01-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -252.127 988.040 -20,33 13,12 -3.307.906 12.963.085
2014-01-13 2014-01-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -42.911 235.476 -15,41 12,40 -532.096 2.919.902
2014-01-13 2014-01-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -225.996 1.240.167 -15,41 12,40 -2.802.350 15.378.071
2014-01-07 2014-01-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -255 278.387 -0,09 12,06 -3.075 3.357.347
2014-01-07 2014-01-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -1.345 1.466.163 -0,09 12,06 -16.221 17.681.926
2014-01-07 2014-01-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -8.592 278.642 -2,99 12,01 -103.190 3.346.490
2014-01-07 2014-01-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -45.258 1.467.508 -2,99 12,01 -543.549 17.624.771
2014-01-03 2014-01-02 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 9.339 24.575 61,30
2014-01-03 2013-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 215 15.236 1,43 11,61 2.496 176.890
2013-11-19 2013-11-15 4 ANAC Anacor Pharmaceuticals, Inc.
Common Stock
S - Sale -150.000 3.575.535 -4,03 14,06 -2.109.000 50.272.022
2013-11-18 2013-11-14 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
S - Sale -575.000 5.458.233 -9,53 12,22 -7.026.500 66.699.607
2013-11-07 2013-11-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
C - Conversion 287.234 287.234
2013-11-07 2013-11-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -287.234 0 -100,00
2013-11-07 2013-11-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
C - Conversion 1.512.766 1.512.766
2013-11-07 2013-11-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -1.512.766 0 -100,00
2013-11-07 2013-11-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
C - Conversion 1.862.497 1.862.497
2013-11-07 2013-11-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -1.862.497 0 -100,00
2013-10-02 2013-09-30 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 211 15.232 1,40 11,84 2.498 180.347
2013-09-12 2013-09-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -900.000 1.862.497 -32,58
2013-07-02 2013-06-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 251 15.272 1,67 9,93 2.492 151.651
2013-06-20 2013-06-19 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (right to buy)
A - Award 30.000 30.000
2013-04-01 2013-03-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 136 15.157 0,91 18,29 2.487 277.222
2013-03-20 2013-03-19 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other 105 105
2013-03-20 2013-03-19 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -12.097 36.290 -25,00
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other 21 15.021 0,14
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other 18.910 18.910
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other 7.483 7.483
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other 88.262 88.262
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -95.745 287.234 -25,00
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -504.255 1.512.766 -25,00
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -920.832 2.762.497 -25,00
2013-03-19 2013-03-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -639.901 1.919.704 -25,00
2013-01-03 2012-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 225 15.788 1,45 11,08 2.493 174.931
2012-10-02 2012-09-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 195 15.563 1,27 12,78 2.492 198.895
2012-09-24 2012-09-20 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
S - Sale -19.273 3.725.535 -0,51 6,30 -121.457 23.477.949
2012-09-18 2012-09-14 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
S - Sale -35.000 3.744.808 -0,93 6,51 -227.804 24.373.832
2012-09-13 2012-09-13 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
S - Sale -15.000 3.779.808 -0,40 6,56 -98.330 24.777.775
2012-09-13 2012-09-11 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
S - Sale -10.177 3.794.808 -0,27 6,64 -67.603 25.207.771
2012-08-09 2012-08-07 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
P - Purchase 685.000 6.033.233 12,81 5,00 3.423.972 30.157.115
2012-08-06 2012-08-06 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
P - Purchase 20.000 5.348.233 0,38 4,88 97.700 26.126.118
2012-08-06 2012-08-03 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
P - Purchase 5.000 5.328.233 0,09 4,85 24.252 25.844.594
2012-08-06 2012-08-02 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
P - Purchase 35.000 5.323.233 0,66 4,61 161.452 24.555.542
2012-07-05 2012-07-02 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
J - Other 79.450 3.804.985 2,13
2012-07-05 2012-07-02 4 ANAC Anacor Pharmaceuticals Inc
Common Stock
J - Other -900.000 3.725.535 -19,46
2012-07-02 2012-06-29 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 181 15.368 1,19 13,78 2.494 211.771
2012-06-18 2012-06-14 4 ZLTQ Zeltiq Aesthetics Inc
Stock Option (right to buy)
A - Award 9.536 9.536
2012-06-15 2012-06-14 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
P - Purchase 37.727 5.288.233 0,72 4,79 180.882 25.354.433
2012-06-15 2012-06-13 4 ZLTQ Zeltiq Aesthetics Inc
Common Stock
P - Purchase 19.879 5.250.506 0,38 4,51 89.728 23.699.209
2012-06-08 2012-06-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Shares
C - Conversion -15.000 0 -100,00
2012-06-08 2012-06-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
C - Conversion 15.000 15.187 8.021,39
2012-04-03 2012-03-30 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 187 187 13,31 2.489 2.489
2012-01-04 2011-12-30 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 208 208
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
15.000
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
2.559.605
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
3.683.329
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
48.387
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
2.017.021
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
382.979
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
40.000
2010-01-05 3/A NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
4.044.789
2010-01-05 3/A NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
739.900
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)